Status:
COMPLETED
Evaluation of the Levels of Salivary Paxillin Oral Premalignant and Malignant Lesions
Lead Sponsor:
Cairo University
Collaborating Sponsors:
Olfat Shaker
Conditions:
Comparison of Salivary Paxillin Levels in OPMLs and OSCC to Healthy Subjects
Eligibility:
All Genders
30-70 years
Brief Summary
This investigation was carried out to analyze and compare the salivary paxillin levels between oral premalignant and malignant lesions (OPMLs), OSCC and the healthy controls in order to assess its pot...
Detailed Description
The aim of this study is: comparison of salivary paxillin levels in oral premalignant lesions and OSCC to its levels in healthy subjects. Subjects and Methods Forty-five participants between the ages...
Eligibility Criteria
Inclusion
- patients with leukoplakia patients with atropic lichen planus patients with bullous erosive lichen planus patients with squamous cell carcinoma
Exclusion
- patients with papular lichen planus patients with underlying systemic disease leukemic patients smokers hepatic patients
Key Trial Info
Start Date :
November 29 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2023
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06154551
Start Date
November 29 2022
End Date
November 1 2023
Last Update
December 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dentistry
Cairo, Egypt